• 1. An automatic determination of thoria in thoria-urania mixtures
  Analyst, 1966,91, 208-210
• 2. An atmosphere and light tuned highly diastereoselective synthesis of cyclobuta/penta[b]indoles from aniline-tethered alkylidenecyclopropanes with alkynes?
  Bo Cao,Yin Wei Chem. Commun., 2018,54, 2870-2873
• 3. Alumina coating on 5 V lithium cobalt fluorophosphate cathode material for lithium secondary batteries – synthesis and electrochemical properties?
  S. Amaresh,K. Karthikeyan,K. J. Kim,Y. S. Lee RSC Adv., 2014,4, 23107-23115
• 4. Acenaphthenic hopanoids, a novel series of aromatised
  Teresita Carrillo-Hernández,Philippe Schaeffer,Pierre Albrecht Chem. Commun., 2001, 1976-1977
• 5. An amorphous lanthanum–iridium solid solution with an open structure for efficient water splitting?
  Wei Sun,Chenglong Ma,Xinlong Tian,Jianjun Liao,Ji Yang,Chengjun Ge,Weiwei Huang J. Mater. Chem. A, 2020,8, 12518-12525

• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Xylenols
• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Xylenes Xylenols

3,5-Dimethyl-2-hydroxymandelic Acid (CAS No. 73499-84-0): Properties, Applications, and Market Insights

3,5-Dimethyl-2-hydroxymandelic acid (CAS No. 73499-84-0) is a specialized organic compound with growing interest in pharmaceutical and biochemical research. This hydroxymandelic acid derivative features unique structural characteristics due to the presence of both hydroxyl and carboxyl functional groups, along with methyl substitutions at the 3 and 5 positions. Researchers frequently search for "synthesis of 3,5-dimethyl-2-hydroxymandelic acid" or "biological activity of hydroxymandelic acid derivatives," reflecting its relevance in drug discovery and metabolic studies.

The compound's molecular formula is C₁₀H₁₂O₄, with a molecular weight of 196.20 g/mol. Its crystalline structure and moderate solubility in polar solvents make it valuable for chiral synthesis applications. Recent publications highlight its potential as a building block for pharmaceutical intermediates, particularly in developing anti-inflammatory compounds and neuromodulators. The presence of both acidic and phenolic hydroxyl groups allows for versatile chemical modifications, a topic frequently explored in queries like "functionalization of 3,5-dimethyl-2-hydroxymandelic acid".

In analytical chemistry, 3,5-dimethyl-2-hydroxymandelic acid serves as a reference standard for HPLC method development, especially for separating aromatic acid analogs. Its UV absorption characteristics (typically λ_max ~275 nm) make it suitable for spectrophotometric detection. Laboratories often search for "HPLC conditions for 3,5-dimethyl-2-hydroxymandelic acid separation" or "stability studies of mandelic acid derivatives," indicating practical research applications.

The compound's stereochemical properties have attracted attention in asymmetric synthesis. The chiral center at the 2-position allows for the creation of enantiomerically pure compounds, with researchers investigating "enantioselective reactions using 3,5-dimethyl-2-hydroxymandelic acid." Recent studies suggest potential applications in designing enzyme inhibitors, particularly those targeting tyrosine metabolism pathways.

Market analysis shows increasing demand for 3,5-dimethyl-2-hydroxymandelic acid in the fine chemicals sector, with annual growth projections of 6-8% in research applications. Suppliers frequently receive inquiries about "bulk availability of CAS 73499-84-0" and "custom synthesis of substituted mandelic acids." The compound's stability under standard storage conditions (recommended at 2-8°C in amber glass containers) contributes to its handling advantages.

Environmental and safety studies confirm that 3,5-dimethyl-2-hydroxymandelic acid exhibits favorable biodegradation profiles, aligning with green chemistry principles. This characteristic responds to growing searches for "eco-friendly aromatic acid derivatives" and "sustainable chiral building blocks." The compound's LD₅₀ values (typically >2000 mg/kg in rodent studies) support its classification as low-toxicity material for research purposes.

Emerging applications include its use in advanced material science, particularly as a monomer for functional polymer synthesis. The phenolic hydroxyl group enables participation in various polycondensation reactions, answering frequent queries about "polymeric derivatives of hydroxymandelic acids." Recent patents highlight its incorporation into pH-responsive materials and drug delivery systems.

Quality control specifications for 3,5-dimethyl-2-hydroxymandelic acid typically require ≥98% purity (HPLC), with strict limits on related substances. Analytical certificates often include data from NMR spectroscopy (characteristic peaks at δ 7.2-7.4 ppm for aromatic protons) and mass spectrometry (m/z 196 for molecular ion). These parameters address common search terms like "spectral data of CAS 73499-84-0" and "purity analysis methods for mandelic acid derivatives."

The scientific community continues exploring novel derivatives of 3,5-dimethyl-2-hydroxymandelic acid, particularly for bioactive compound development. Recent publications investigate its metal-chelating properties and potential in catalysis applications, responding to trending searches about "transition metal complexes with hydroxymandelic acids." These developments position the compound as a versatile scaffold in medicinal chemistry and material innovation.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)